Categories: Market Research

Biopsy Devices Market 2024 | Business Growth, Industry Trends, Size, Key Drivers, Top Players And Forecast To 2033

Overview and Scope
The biopsy devices are used to extract sample cells or tissues from the patient’s body to be examined to determine the presence of a disease.

Sizing and Forecast
The biopsy devices market size has grown strongly in recent years. It will grow from $2.87 billion in 2023 to $3.11 billion in 2024 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to emerging markets growth, advancement in healthcare infrastructure and growth in the elderly population..

The biopsy devices market size is expected to see strong growth in the next few years. It will grow to $4.29 billion in 2028 at a compound annual growth rate (CAGR) of 8.4%. The growth in the forecast period can be attributed to government investments in healthcare sector, rising cancer cases and an increase in healthcare expenditure will drive the market growth. . Major trends in the forecast period include technological advancements, launch of fully automatic biopsy systems, product innovations, development of robot-assisted biopsy systems, partnerships and collaborations and increasing investments..

Order your report now for swift delivery, visit the link:
https://www.thebusinessresearchcompany.com/report/biopsy-devices-global-market-report

The biopsy devices market covered in this report is segmented –

1) By Product Type: Needle-Based Biopsy Guns, Biopsy Forceps, Biopsy Guidance Systems, Biopsy Needles, Other Products
2) By Image Guiding Technology: MRI-Guided Biopsy, Stereotactic-Guided Biopsy, Ultrasound-Guided Biopsy, Other Imaging Technologies
3) By Application: Breast Biopsy, Gynecological Biopsy, Prostate Biopsy, Blood Cancers Biopsy, Skin Biopsy, Kidney Biopsy, Gastroenterology Biopsy, Other Applications
4) By End User: Diagnostics And Imaging Centers, Hospitals, Other End User

North America was the largest region in the biopsy devices market in 2023. Asia-Pacific was the second largest region in the global biopsy devices market report share. The regions covered in the biopsy devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Intrigued to explore the contents? Secure your hands-on a free sample copy of the report:
https://www.thebusinessresearchcompany.com/sample_request?id=3283&type=smp

Major Driver Impacting Market Growth

The rise in the number of cancer cases contributed to the growth of the biopsy devices market. A biopsy is a primary approach used by doctors to diagnose any abnormalities in the bodies if the presence of cancer cells is suspected. For instance, in January 2023, the American Cancer Society, a US-based a nationwide voluntary health organization dedicated to eliminating cancer, stated that around 1.9 million new cancer cases are anticipated to be diagnosed in the United States in 2022, with an estimated 609,360 cancer-related deaths. Specifically, approximately 151,030 new cases of colorectal cancer are expected to be identified by the end of 2022, and it is projected to lead to roughly 52,550 deaths in 2023. Furthermore, in May 2022, Canadian Medical Association Journal, a Canada-based peer-reviewed open-access general medical journal published by the Canadian Medical Association, in its report stated that in Canada, it is estimated that approximately 233,900 new cases of cancer will be diagnosed in 2022. Among these cases, around 28,600 are projected to be breast cancer, constituting approximately 25% of all newly diagnosed cancer cases in women for that year. The most prevalent type of cancer anticipated in Canada in 2022 is lung cancer, with an estimated 30,000 new cases.

Key Industry Players

Major companies operating in the biopsy devices market report are Becton Dickinson and Company (BD), Hologic, Inc., Danaher Corporation, Boston Scientific Corporation, Olympus Corporation, Cook Medical, Medtronic Inc, Cardinal Health, Argon Medical Devices Inc., Fujifilm Holdings Corp, A&T Corporation, BMA Co. Ltd., Transmed (China) Co., LTD, HaploX Biotechnology, Gene+sLab, Lepu Medical Technology, Digirad Corporation, CMR Naviscan Corporation, DDD Diagnostics, Philips Healthcare, Siemens Healthineers, Abbott Laboratories, Bangs Laboratories Inc, Roche Diagnostics, Cepheid, Devicor Medical Products, Braile Biomedica Ltd, B.Braun Medical Gulf, Stryker ESCS BV

The biopsy devices market report table of contents includes:

1. Executive Summary

2. Biopsy Devices Characteristics

3. Biopsy Devices Trends And Strategies

4. Biopsy Devices – Macro Economic Scenario

5. Global Biopsy Devices Size and Growth

…..

32. Global Biopsy Devices Competitive Benchmarking

33. Global Biopsy Devices Competitive Dashboard

34. Key Mergers And Acquisitions In The Biopsy Devices

35. Biopsy Devices Future Outlook and Potential Analysis

36. Appendix